Literature DB >> 24372861

Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.

Jianye Yuan1, Susan S Baker, Wensheng Liu, Razan Alkhouri, Robert D Baker, Jianqun Xie, Guang Ji, Lixin Zhu.   

Abstract

BACKGROUND AND AIM: Nonalcoholic steatohepatitis (NASH), the severe form of nonalcoholic fatty liver disease, is a serious liver complication associated with obesity. Several studies suggest that endotoxemia is associated with nonalcoholic fatty liver disease and NASH. We aimed to study the correlation of gut microbiome composition and the incidence of endotoxemia in obese patients and NASH patients in comparison with normal controls.
METHODS: The abundance of Gram-negative bacteria in the gut microbiomes of normal controls, obese patients with normal liver, and biopsy-proven NASH patients were assessed using 16S rRNA pyrosequencing data. Serum endotoxin was determined by endpoint limulus amebocyte lysate assay.
RESULTS: Higher abundance of Gram-negative bacteria in gut microbiome was observed in obese and NASH patients in comparison with normal controls, but no difference was detected between obese and NASH patients. Serum endotoxin is higher in the NASH group than the normal controls. In addition, the obese and NASH patients had a higher incidence of endotoxemia compared with normal controls. However, Spearman's test found no correlation between the abundance of Gram-negative bacteria and serum endotoxin levels. The majority of the NASH patients and the obese patients had low serum endotoxin level. Among NASH patients, serum endotoxin is not correlated with disease severity.
CONCLUSIONS: Our data suggest that the gut microbiome composition does not contribute to the incidence of endotoxemia in NASH, and endotoxemia is not required in the pathogenesis of NASH. Our observations highlight the current concept that multiple factors contribute to the development of NASH.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Gram-negative; endotoxin; lipopolysaccharide; microbiome

Mesh:

Substances:

Year:  2014        PMID: 24372861     DOI: 10.1111/jgh.12510

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  27 in total

Review 1.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

Review 2.  Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?

Authors:  Lu Jiang; Bernd Schnabl
Journal:  Physiology (Bethesda)       Date:  2020-07-01

3.  Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress.

Authors:  Rosa Zampino; Aldo Marrone; Luca Rinaldi; Barbara Guerrera; Riccardo Nevola; Adriana Boemio; Natalina Iuliano; Mauro Giordano; Nicola Passariello; Ferdinando C Sasso; Emanuele Albano; Luigi E Adinolfi
Journal:  Infection       Date:  2018-07-31       Impact factor: 3.553

Review 4.  Leaky gut: mechanisms, measurement and clinical implications in humans.

Authors:  Michael Camilleri
Journal:  Gut       Date:  2019-05-10       Impact factor: 23.059

Review 5.  Gut Microbiota of Nonalcoholic Fatty Liver Disease.

Authors:  Reham M Abdou; Lixin Zhu; Robert D Baker; Susan S Baker
Journal:  Dig Dis Sci       Date:  2016-02-22       Impact factor: 3.199

Review 6.  Pathogenesis of nonalcoholic steatohepatitis.

Authors:  Wensheng Liu; Robert D Baker; Tavleen Bhatia; Lixin Zhu; Susan S Baker
Journal:  Cell Mol Life Sci       Date:  2016-02-19       Impact factor: 9.261

Review 7.  Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

Authors:  Sena Bluemel; Brandon Williams; Rob Knight; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-29       Impact factor: 4.052

8.  Dietary copper-fructose interactions alter gut microbial activity in male rats.

Authors:  Ming Song; Xiaohong Li; Xiang Zhang; Hongxue Shi; Miriam B Vos; Xiaoli Wei; Yuhua Wang; Hong Gao; Eric C Rouchka; Xinmin Yin; Zhanxiang Zhou; Russell A Prough; Matthew C Cave; Craig J McClain
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-10-12       Impact factor: 4.052

Review 9.  Non-alcoholic fatty liver diseases: current challenges and future directions.

Authors:  Elke Roeb
Journal:  Ann Transl Med       Date:  2021-04

10.  Endotoxin Biomarkers Are Associated With Adiposity and Cardiometabolic Risk Across 6 Years of Follow-up in Youth.

Authors:  Wei Perng; Jacob E Friedman; Rachel C Janssen; Deborah H Glueck; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.